Who
Nathaniel Goldhaber
Director
Company insider
Files Form 4 as: Director, Chewy; 10% owner, Natera.
In numbers
- Trades disclosed
- 14
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $144K
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 11 May 2018
- Last trade
- 9 Jul 2026
- Last filed
- 13 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jul 2026filed 13 Jul 2026 | CHWY ChewyE-Commerce & Marketplaces | SEC FORM 4 Code A | —10,665 at $0.00 | filing |
| 9 Jul 2026filed 13 Jul 2026 | CHWY ChewyE-Commerce & Marketplaces | SEC FORM 4 Code A | —10,665 at $0.00 | filing |
| 14 Jul 2025filed 16 Jul 2025 | CHWY ChewyE-Commerce & Marketplaces | SEC FORM 4 Code A | —4,921 at $0.00 | filing |
| 24 Apr 2025filed 28 Apr 2025 | CHWY ChewyE-Commerce & Marketplaces | SEC FORM 4 Code A | —1,304 at $0.00 | filing |
| 14 May 2018filed 17 May 2018 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $11K994 at $11.48 | filing |
| 14 May 2018filed 17 May 2018 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $16K1,424 at $11.48 | filing |
| 14 May 2018filed 17 May 2018 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $9,505828 at $11.48 | filing |
| 14 May 2018filed 17 May 2018 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $106K9,267 at $11.48 | filing |
| 11 May 2018filed 17 May 2018 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Code J | —295,242 | filing |
| 11 May 2018filed 17 May 2018 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Code J | —10,018 | filing |
| 11 May 2018filed 17 May 2018 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Code J | —2,982 | filing |
| 11 May 2018filed 17 May 2018 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Code J | —4,273 | filing |
| 11 May 2018filed 17 May 2018 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Code J | —107 | filing |
| 11 May 2018filed 17 May 2018 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Code J | —2,483 | filing |
News
Financial Comparison: Valneva (NASDAQ:VALN) and Natera (NASDAQ:NTRA)NTRA · tickerreport.com · 22 Oct 2026Natera (NTRA) Is Expanding Cancer Testing Rapidly. Does Its Valuation Leave Room for Error?NTRA · insidermonkey.com · 20 Oct 2026ESMO 2026 Presentations Deepen the Evidence Base for Natera's Oncology Portfolio and Leadership in Ultrasensitive MRD Technology | wallstreetONLINENTRA · wallstreet-online.de · 19 Oct 2026
0 headlines in the last 90 days name Nathaniel Goldhaber; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.